411
Views
8
CrossRef citations to date
0
Altmetric
Research Article

QSAR of aromatic substances: MAO inhibitory activity of xanthone derivatives

, &
Pages 277-286 | Received 29 Aug 2006, Accepted 03 Nov 2006, Published online: 04 Oct 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (7)

Camilla Badiali, Valerio Petruccelli, Elisa Brasili & Gabriella Pasqua. (2023) Xanthones: Biosynthesis and Trafficking in Plants, Fungi and Lichens. Plants 12:4, pages 694.
Crossref
Maria I Cruz, Honorina Cidade & Madalena Pinto. (2017) Dual/multitargeted xanthone derivatives for Alzheimer's disease: where do we stand?. Future Medicinal Chemistry 9:14, pages 1611-1630.
Crossref
Alexandra Gaspar, Tiago Silva, Matilde Yáñez, Dolores Vina, Franscisco Orallo, Francesco Ortuso, Eugenio Uriarte, Stefano Alcaro & Fernanda Borges. (2011) Chromone, a Privileged Scaffold for the Development of Monoamine Oxidase Inhibitors. Journal of Medicinal Chemistry 54:14, pages 5165-5173.
Crossref
Stefano Alcaro, Alexandra Gaspar, Francesco Ortuso, Nuno Milhazes, Francisco Orallo, Eugenio Uriarte, Matilde Yáñez & Fernanda Borges. (2010) Chromone-2- and -3-carboxylic acids inhibit differently monoamine oxidases A and B. Bioorganic & Medicinal Chemistry Letters 20:9, pages 2709-2712.
Crossref
Omar Deeb & Brian W. Clare. (2008) QSAR of heterocyclic antifungal agents by flip regression. Journal of Computer-Aided Molecular Design 22:12, pages 885-895.
Crossref
Omar Deeb & Brian W. Clare. (2008) Comparison of AM1 and B3LYP-DFT for Inhibition of MAO-A by Phenylisopropylamines: A QSAR Study. Chemical Biology & Drug Design 71:4, pages 352-362.
Crossref
Omar Deeb & Brian W. Clare. (2007) QSAR of Aromatic Substances: Protein Tyrosine Kinase Inhibitory Activity of Flavonoid Analogues. Chemical Biology & Drug Design 70:5, pages 437-449.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.